Form 4: Teva Pharmaceutical Executive Vice President Sells 45,060 Shares

Eric A. Hughes, Executive Vice President at Teva Pharmaceutical Industries Ltd, sold 45,060 ordinary shares at a weighted average price of $17.3762 on August 9, 2024.

Summary

• On August 9, 2024, Eric A. Hughes, an Executive Vice President at Teva Pharmaceutical Industries Ltd, sold 45,060 ordinary shares of the company.
• The shares were sold at a weighted average price of $17.3762.
• The price range for the multiple transactions was between $17.371 and $17.405.
• Following the transaction, the reporting person still beneficially owns securities of Teva Pharmaceutical Industries Ltd.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a transaction by a company insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the sale of shares.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies and can be influenced by a variety of factors, including personal financial planning and company performance. It's important to consider the broader context of Teva's performance and industry trends when interpreting this transaction.

Stakeholder Impact

• The sale of shares by a company executive could be perceived differently by stakeholders.
• Some may view it as a lack of confidence in the company's future, while others may see it as a normal part of executive compensation and financial planning.

Key Dates